68 filings
8-K
PHGE
BiomX Inc
15 Apr 24
Departure of Directors or Certain Officers
5:19pm
8-K
PHGE
BiomX Inc
3 Apr 24
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7:40am
8-K
PHGE
BiomX Inc
18 Mar 24
Completion of Acquisition or Disposition of Assets
7:27am
8-K
PHGE
BiomX Inc
6 Mar 24
Form of Parent Stockholder Support Agreement
7:45am
8-K
PHGE
BiomX Inc
7 Dec 23
Entry into a Material Definitive Agreement
5:29pm
8-K
u11zfi6njwg6 q1cbc1
7 Dec 23
Other Events
4:09pm
8-K
6ta6gfrk5uqppx f1f
29 Nov 23
Revolutionizing the treatment of Cystic Fibrosis through our unique BOLT Phage therapy platform Investor Presentation / November 2023
6:37am
8-K
7evh511o53v
14 Nov 23
BiomX Reports Third Quarter 2023 Financial Results and Provides Business Update
12:00am
8-K
wiekuro py
31 Oct 23
Departure of Directors or Certain Officers
5:05pm
8-K
2rmhrijiwhnjrkcct8
18 Oct 23
Departure of Directors or Certain Officers
8:30am
8-K
c2qdr
29 Aug 23
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
a46a do8s4ree8lz25
9 Aug 23
BiomX Reports Second Quarter 2023 Financial Results and Provides Business Update
6:48am
8-K
b8fjpbk1tk51h7gd
20 Jun 23
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
0e204p mcw4c8
8 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
lebwr1go9oc9n1417su
15 May 23
BiomX Reports First Quarter 2023 Financial Results and Provides Business Update
7:53am
8-K
8p6sbsau3qk nuc
5 May 23
Unregistered Sales of Equity Securities
9:00am
8-K
6xxn xgeg7zk
25 Apr 23
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
zl0jr xzm7
29 Mar 23
BiomX Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
7:45am
8-K
c0cn0gotfyr0278vsdz
27 Feb 23
Entry into a Material Definitive Agreement
5:10pm
8-K
31bu wsb7
22 Feb 23
Revolutionizing the treatment of Cystic Fibrosis through our unique BOLT Phage therapy platform Investor Presentation / Jan 2023
3:05pm